Table 6.
January 2010 |
January 2012 |
|||
---|---|---|---|---|
EQ-5D-3L | EQ-5D-5L | EQ-5D-3L | EQ-5D-5L | |
(actual) | (predicted) | (predicted) | (actual) | |
Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | |
Overall | 0.70 | 0.79 | 0.69 | 0.78 |
(0.25) | (0.16) | (0.21) | (0.19) | |
Severity group | ||||
Mild | 0.88 | 0.92 | 0.87 | 0.92 |
(HAQ group 1, Pain group 1) | (0.12) | (0.04) | (0.08) | (0.07) |
Medium | 0.62 | 0.71 | 0.61 | 0.73 |
(HAQ group 2, Pain group 3) | (0.15) | (0.09) | (0.11) | (0.11) |
Severe | 0.12 | 0.38 | 0.12 | 0.30 |
(HAQ group 3, Pain group 5) | (0.29) | (0.16) | (0.19) | (0.23) |
Female <65 | 0.69 | 0.78 | 0.68 | 0.77 |
(0.26) | (0.17) | (0.23) | (0.20) | |
Male<65 | 0.71 | 0.80 | 0.67 | 0.77 |
(0.25) | (0.16) | (0.24) | (0.21) | |
Female 65–79 | 0.71 | 0.79 | 0.69 | 0.79 |
(0.24) | (0.15) | (0.20) | (0.18) | |
Male 65–79 | 0.73 | 0.82 | 0.73 | 0.83 |
(0.22) | (0.14) | (0.18) | (0.14) | |
Female ≥ 80 | 0.65 | 0.76 | 0.66 | 0.76 |
(0.25) | (0.17) | (0.20) | (0.18) | |
Male ≥ 80 | 0.74 | 0.83 | 0.70 | 0.80 |
(0.17) | (0.12) | (0.17) | (0.16) |